HIGHLIGHTS
- who: Shuo Qie from the (UNIVERSITY) have published the research: Stanniocalcin 2 (STC2): a universal tumour biomarker and a potential therapeutical target, in the Journal: (JOURNAL)
- future: Since STC2 is a secreted protein its serum levels can be applied as a biomarker to evaluate the progression of RCC but further investigations are required to clarify this probability. Studies are required to dissect how STC2 expression is controlled in cells under various stress conditions and how it regulates biological processes in stressed cells.
SUMMARY
Analysis. Gene expression profiling and interactive analysis (GEPIA . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.